The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension

Philipp Angleitner, Thomas Schlöglhofer, Dominik Wiedemann, Julia Riebandt, Andreas Strassl, Julia Mascherbauer, Matthias Kainz, Günther Laufer, Andreas Zuckermann, Daniel Zimpfer

Publikation: Beitrag in Fachzeitschrift (peer-reviewed)Artikel in Fachzeitschrift

2 Zitate (Scopus)

Abstract

Fixed pulmonary hypertension (FPH) is a contraindication for heart transplantation (HTX). However, this condition might be reversed by continuous left-ventricular unloading with a left-ventricular assist device. We present a case of apical hypertrophic cardiomyopathy with extensive left-ventricular endocardial calcification and severe FPH (systolic pulmonary artery pressure, 102 mm Hg). To bridge the patient to candidacy for HTX, two Abbott HeartMate 3 ventricular assist devices were implanted in a total artificial heart (TAH) configuration ("HeartMate 6"). Before TAH implantation, an Abbott CardioMEMS pressure sensor was implanted to assess reversal of FPH before listing for HTX.

OriginalspracheEnglisch
Seiten (von - bis)e80-e83
FachzeitschriftASAIO Journal
Jahrgang68
Ausgabenummer5
DOIs
PublikationsstatusVeröffentlicht - 01 Mai 2022

Fingerprint

Untersuchen Sie die Forschungsthemen von „The HeartMate 6 and CardioMEMS for Fixed Pulmonary Hypertension“. Zusammen bilden sie einen einzigartigen Fingerprint.

Dieses zitieren